Inna Tsypysheva

Dr. Inna Tsypysheva

Ufa Federal Research Center of Russian Academy od Sciences
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2012 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
ITInna Tsypysheva
Inna Tsypysheva
AKA. V. Koval’skaya
A. V. Koval’skaya
NMN. S. Makara
N. S. Makara
ALAlexander N. Lobov
Alexander N. Lobov
IPI. A. Petrenko
I. A. Petrenko
MYM. S. Yunusov
M. S. Yunusov

11 July 2018 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SKSergey Kuranov
Sergey Kuranov
ITInna Tsypysheva
Inna Tsypysheva
Mikhail KhvostovMikhail Khvostov
Mikhail Khvostov
LZLiana F. Zainullina
Liana F. Zainullina
Sophia S. BorisevichSophia S. Borisevich
Sophia S. Borisevich
NSN.F. Salakhutdinov
N.F. Salakhutdinov

2 December 2019 in Natural Product Research
Verified
Journal Article
Closed access
VFVictoria A. Fedorova
Victoria A. Fedorova
RKRenata A. Kadyrova
Renata A. Kadyrova
ASAlexander V. Slita
Alexander V. Slita
AMAnna A. Muryleva
Anna A. Muryleva
PPPolina R. Petrova
Polina R. Petrova
VZVladimir V. Zarubaev
Vladimir V. Zarubaev
Novel derivatives of quinolizidine alkaloid (−)-cytisine were synthesised. ADME properties, cytotoxicity against HEK293 cells and activity against viruses of influenza A/California/07/09(H1N1)pdm09 virus (IAV) and human parainfluenza virus type 3 (HPIV3) were evaluated. It was shown, that 9-carboxamides of methylcytisine (with phenyl and allyl urea’s fragments) are most active compounds against IAV probably due to predicted in silico peculiarity of their interactions with the 4R7B active site of IAV neuraminidase. Indexes of selectivity (SI) calculated as ratio of CC50/IC50 of these ureas are 47 and 59 correspondingly. It was also found, that derivatives obtained from allyl isocyanate and (−)-cytisine or 9,11-dibromocytisine are able to inhibit a reproduction of HPIV3 with SI = 58 and 95. Moreover, last compound - (1 R,5R)-N-allyl-9,11-dibromo-8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocine-3(4H)-carboxamide with two bromine atom in 2-pyridone core of starting (−)-cytisine molecule, demonstrated high activity against HPIV3 (SI = 95) and moderate activity against IAV (SI = 16).

Verified
Journal Article
Open access
PDF file
MVMikhail Voronin
Mikhail Voronin
YVYulia Vakhitova
Yulia Vakhitova
ITInna Tsypysheva
Inna Tsypysheva
DTDmitrii Tsypyshev
Dmitrii Tsypyshev
IRInna V. Rybina
Inna V. Rybina
SSSergei B. Seredenin
Sergei B. Seredenin
Sigma-1 receptor (chaperone Sigma1R) is an intracellular protein with chaperone functions, which is expressed in various organs, including the brain. Sigma1R participates in the regulation of physiological mechanisms of anxiety (Su, T. P. et al., 2016) and reactions to emotional stress (Hayashi, T., 2015). In 2006, fabomotizole (ethoxy-2-[2-(morpholino)-ethylthio]benzimidazole dihydrochloride) was registered in Russia as an anxiolytic (Seredenin S. and Voronin M., 2009). The molecular targets of fabomotizole are Sigma1R, NRH: quinone reductase 2 (NQO2), and monoamine oxidase A (MAO-A) (Seredenin S. and Voronin M., 2009). The current study aimed to clarify the dependence of fabomotizole anxiolytic action on its interaction with Sigma1R and perform a docking analysis of fabomotizole interaction with Sigma1R. An elevated plus maze (EPM) test revealed that the anxiolytic-like effect of fabomotizole (2.5 mg/kg i.p.) administered to male BALB/c mice 30 min prior EPM exposition was blocked by Sigma1R antagonists BD-1047 (1.0 mg/kg i.p.) and NE-100 (1.0 mg/kg i.p.) pretreatment. Results of initial in silico study showed that fabomotizole locates in the active center of Sigma1R, reproducing the interactions with the site’s amino acids common for established Sigma1R ligands, with the ΔGbind value closer to that of agonist (+)-pentazocine in the 6DK1 binding site.

1 January 2013 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
ITInna Tsypysheva
Inna Tsypysheva
AKA. V. Koval’skaya
A. V. Koval’skaya
ALAlexander N. Lobov
Alexander N. Lobov
VZV. V. Zarubaev
V. V. Zarubaev
LKL. A. Karpinskaya
L. A. Karpinskaya
MYM. S. Yunusov
M. S. Yunusov

1 December 2021 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ITInna Tsypysheva
Inna Tsypysheva
HLHsueh-Chou Lai
Hsueh-Chou Lai
YKYan-Tung Kiu
Yan-Tung Kiu
AKAlena V. Koval'Skaya
Alena V. Koval'Skaya
DTDmitry O. Tsypyshev
Dmitry O. Tsypyshev
Cheng-Wen LinCheng-Wen Lin
Cheng-Wen Lin